JaxBio Technologies
PrivateLast Round
Grant
Jul 16, 2024
Total Funding Raised
$4.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
JaxBio Technologies operates in Healthcare & Life Sciences and is based in Netanya. Its latest recorded funding round was a Grant round in July 2024.
JaxBio Technologies is a health tech company that develops an AI-based platform for genetic and epigenetic profiling to enable early cancer detection and monitoring through blood-based diagnostic tests.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
JaxBio Technologies Comparables
Compare JaxBio Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuamark Diagnostics | 84% | |
| EarlyDiagnostics | 83% | |
| Aqtual | 82% |
For institutional investors. Book with your work email.
JaxBio Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 16, 2024 | ||||
| Grant | Jan 1, 2023 | ||||
| Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
JaxBio Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Ramot at Tel Aviv University | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 569% MoM, reaching 4.7K.
- Jul 25, 2026
Monthly visitors increased 83% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 4, 2026
JaxBio Technologies Ltd. receives $12M in financing and conducts clinical trials at hospitals in Israel and Europe.
For institutional investors. Book with your work email.
JaxBio Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about JaxBio Technologies's valuation, stock price, and market status.
Is JaxBio Technologies a public or private company?
JaxBio Technologies is a private company.
What is the current stock price of JaxBio Technologies?
JaxBio Technologies is a private company, so its shares have no public market price. Caplight tracks JaxBio Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is JaxBio Technologies worth (valuation)?
Valuation information for JaxBio Technologies is not publicly available.
Can I buy JaxBio Technologies stock?
JaxBio Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was JaxBio Technologies's last funding round?
JaxBio Technologies's most recent funding round was Grant on July 16, 2024.
Who are the main investors in JaxBio Technologies?
Key investors in JaxBio Technologies include Ramot at Tel Aviv University.
Will JaxBio Technologies IPO soon?
No public IPO plans have been announced for JaxBio Technologies.
How can I track JaxBio Technologies secondary market activity?
Caplight tracks bids, offers, and trades in JaxBio Technologies's shares on secondary markets.